Ultragenyx Pharmaceutical
RARE
#4539
Rank
C$3.35 B
Marketcap
C$34.06
Share price
1.54%
Change (1 day)
-36.18%
Change (1 year)

P/S ratio for Ultragenyx Pharmaceutical (RARE)

P/S ratio as of June 2026 (TTM): 3.59

According to Ultragenyx Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -33.0. At the end of 2026 the company had a P/S ratio of 2.80.

P/S ratio history for Ultragenyx Pharmaceutical from 2014 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20262.80-17.38%
20253.38-52.71%
20247.16-20.85%
20239.041.15%
20228.94-45.19%
202116.3-51.73%
202033.841.86%
201923.8-44.54%
201842.9-94.32%
2017756-96.5%
2016> 1000
2015N/A
2014N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Lexicon Pharmaceuticals
LXRX
12.1 237.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
2.68-25.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
7.17 99.72%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
3.32-7.54%๐Ÿ‡บ๐Ÿ‡ธ USA